rivastigmine has been researched along with phenethylcymserine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boido, V; Carotti, A; Catto, M; Giangreco, I; Nicolotti, O; Novelli, F; Pisani, L; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M | 1 |
| Edwards, CC; Hatfield, MJ; Hyatt, JL; Potter, PM; Tsurkan, LG | 1 |
2 other study(ies) available for rivastigmine and phenethylcymserine
| Article | Year |
|---|---|
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cattle; Cholinesterase Inhibitors; Crystallography, X-Ray; Dose-Response Relationship, Drug; Erythrocytes; Models, Molecular; Molecular Structure; Quinolizidines; Stereoisomerism; Structure-Activity Relationship | 2011 |
Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors.
Topics: Carboxylesterase; Carboxylic Ester Hydrolases; Cholinesterase Inhibitors; Drug Interactions; Humans; Intestines; Kinetics; Liver; Models, Molecular; Phenylcarbamates; Physostigmine; Recombinant Proteins; Rivastigmine | 2013 |